Validation of a measure of health-related production loss: construct validity and responsiveness - a cohort study by unknown
RESEARCH ARTICLE Open Access
Validation of a measure of health-related
production loss: construct validity and
responsiveness - a cohort study
Malin Lohela Karlsson*, Hillevi Busch, Emmanuel Aboagye and Irene Jensen
Abstract
Background: The aim of this study is to evaluate the construct validity and responsiveness of a Swedish measure
of health-related production loss as well as to investigate if there is a difference in the level of production loss
within a population suffering from persistent back/neck pain and CMDs.
Methods: The sample was drawn from a study that assessed employees’ health and working capacity in 74 health
care units before and after intervention. The study included 692 patients who reported working the previous six
months at baseline measurement, and who were also asked to answer questions related to health-related
production loss. Health-related measures were general health derived from Short Form-12, health-related quality of
life derived from EQ-5D, and work ability derived from the Work Ability Index (WAI). Convergent validity and
external responsiveness were assessed using Spearman’s Rank Correlation Coefficient and a linear regression model,
respectively.
Results: The different measures of health showed a moderate-to-strong correlation with the measure of health-
related production loss and fulfilled the criteria for construct validity. Changes in health and work ability led to
significant changes in health-related production loss, which demonstrates external responsiveness. This result is
valid for both the total population and for the two different subgroups that were evaluated.
Conclusions: The present study shows that this measure of health-related production loss is a valid measure for
capturing production loss due to illness, and that work ability is more strongly correlated with health-related
production loss than people’s general health is. The result shows an average of about 50 % reduced production
due to illness, with back pain being the most costly.
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Background
Reduced productivity at work due to ill health or work
environment problems in the form of absence from
work, as well as reduced performance while at work,
could lead to production losses for both society and for
companies. Losses related to ill health, referred to as
health-related production loss hereafter, have been
highlighted recently in research as well as in society.
Sickness absence was previously the only factor consid-
ered when estimating the cost of production loss from
both the societal and employer perspective. However,
more recent studies have shown that the costs related to
consequences of employees attending work despite being
sick, so-called presenteeism, could be at least twice as
high as the cost of sickness absence [1, 2]. Thus the cost
of production loss due to presenteeism has to be consid-
ered when production losses are estimated even from
the broader societal perspective.
The practical concern, however, has been how lost
production due to ill health is measured [3, 4]. Objective
methods, often adopting computer-based measurements
of health-related production losses, have been used spar-
ingly due to the lack of generalizability of outcomes and
to time constraints on implementation [5]. Instead, the
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use of self-reported productivity instruments is the most
common approach [4, 5]. These self-reported instru-
ments mostly measure indirect costs to the employer
arising from health-related absences and reduced per-
formance while sick but at work. To this end, efforts to
measure productivity have focused on performance-
based approaches to estimate health-related production
loss in order to establish the business value of an em-
ployee’s health as well as to communicate to employers
the reasons for investing in employee health [6–8].
Several productivity valuation instruments have been
developed to capture these losses, some validated and
others not [5, 8, 9]. The challenges, though, lie in the
feasibility of collecting information related to production
loss and how these instruments perform with regard to
measuring productivity-related information, their applic-
ability to real-world businesses, and the possibility of
monetizing health-related production loss [5]. The meas-
urement of production loss as a result of presenteeism
seems to pose more challenges than the measurement of
production loss due to absenteeism because production is
not easily measurable in most cases [8, 10]. Furthermore,
some of the instruments have been developed for a spe-
cific purpose directed towards particular groups and with
varying recall periods also affecting the possibility to cap-
ture these losses [5, 8].
The implication of these challenges, from the em-
ployer’s perspective, is that measuring production loss is
mired in uncertainty as to which measure will accurately
capture the losses. To be useful, a measuring instrument
must therefore: 1) determine if and to what extent health
and work environment problems affect employee per-
formance; 2) be possible to use when evaluating change
over time as part of an intervention evaluation [3]; and
3) be capable of measuring the costs arising from the
particular problem. Such a tool, of course, needs to be
tested for its validity and reliability. A first step is to
make sure that the instruments used capture what they
are intended to capture, which is evaluated in different
validation tests.
Health-related production loss, as measured in this
study, has previously been tested for its construct valid-
ity in a working population [11]. That study indicated
that health-related production loss was explained to a
larger extent by health than by work environment-
related factors. However, this difference was not statisti-
cally significant and the construct validity of this measure
could therefore not be stated [11]. A possible explanation
for this result is that health-related production loss also is
a consequence of work environment-related problems, as
shown in previous studies [12, 13], and it is questionable if
the hypothesis that health-related production loss can be
explained by health alone, without influence from work
environment factors, was judiciously chosen. The current
study expands the validation process for this Swedish
measure developed to capture health-related production
loss by examining its construct validity, and also by exam-
ining responsiveness validity in a population suffering
from persistent back/neck pain or common mental disor-
ders (CMDs). To date, these diagnoses are the two most
common causes of sickness absence in Sweden as well as
in Europe generally, and there has been a lot of focus on
these groups for the prevention of sickness absence or the
rehabilitation of those already on sick leave. These groups
were also the targets of a large, nationally funded rehabili-
tation project launched in Sweden in 2009, from which
data for this study has been drawn.
The specific aim of this study is to evaluate the con-
struct validity and responsiveness of this measure of
health-related production loss. A further aim of the
study is to investigate if there is a difference in the level
of production loss within a population suffering from
persistent back/neck pain and CMDs.
Convergent validity
Construct validity refers to the extent to which a construct
measures the construct it is supposed to measure [14]. In
this study, construct validity was tested by evaluating
expectations about the relationship between different
health-related conditions and health-related production
loss (convergent validity). The validation of a measure-
ment is a process that includes several steps depending on
the characteristics of the measurement and what it is
intended to be used for. The measurement evaluated here
refers to work performance, or production loss, as well as
to those factors that may limit this performance. In this
part of the validation process, the focus is on the later
part, i.e., whether the measurements are able to reflect or
be indicative of health-related factors that may limit work
performance. Work performance per se was not included
in this data collection and is therefore not included in this
validation. However, work ability was measured and is
used as an indicator of performance, as it is related to em-
ployees’ ability to perform at work.
The measure of health-related production loss was
correlated with different measures of health: general
health, health-related quality of life, and work ability. If
these three constructs correlate with health-related pro-
duction loss as defined in the hypothesis below, this indi-
cates convergent validity. First, health-related production
loss was correlated with a question about general health
from the validated questionnaire Short Form-12 (SF-12)
[15]. Previous studies have shown that general health is
weakly-to-strongly correlated with health-related pro-
duction loss [9, 16]. This difference in the strength of
correlation was found for different time points within
the same study population [16], but was also related
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to the different instruments capturing health-related
production loss [9].
Hypothesis H1a General health is expected to have a
moderate negative correlation with health-related pro-
duction loss (r = −0.30 – -0.50).
Hypothesis H1b General health is expected to have a
moderate negative correlation with health-related
production loss in patients suffering from N/B pain
(r = −0.30 – -0.50).
Hypothesis H1c General health is expected to have a mod-
erate negative correlation with health-related production
loss in patients suffering from CMD (r = −0.30 – -0.50).
Second, production loss was correlated with health-
related quality of life (HRQL), measured by the validated
Euroqol questionnaire EQ-5D [17]. HRQL has previously
been shown to be associated with productivity [18, 19].
The degree of correlation has not been expressed. How-
ever, as HRQL is a measure that can be used to capture
general health we assumed that the strength of the correl-
ation for HRQL would equal that of general health.
Hypothesis H2a HRQL is expected to have a moderate
negative correlation with health-related production loss
(r = −0.30 – -0.50).
Hypothesis H2b HRQL is expected to have a moderate
negative correlation with health-related production loss
in patients suffering from N/B pain (r = −0.30 – -0.50).
Hypothesis H2c HRQL is expected to have a moderate
negative correlation with health-related production loss
in patients suffering from CMD (r = −0.30 – -0.50).
Third, health-related production loss was correlated
with the person’s overall work ability, measured using a
question from the Work Ability Index (WAI) [20, 21].
Work ability is normally used as an indicator of an em-
ployee’s ability to perform at work but has seldom been
evaluated in relation to a measurement of health-related
production loss with data collected from the same popu-
lation. One study has tried to evaluate if work ability is a
robust indicator for assessing production loss [22]. How-
ever, this study used estimates of work ability from one
population and modeled it with data on production loss
from another population. The result from the study sug-
gested that work ability is a robust indicator for asses-
sing production loss. Two other studies [23, 24]
evaluated the validity of a different measurement of how
people function at work when experiencing health-
related problems, The Work Role Functioning Question-
naire (WRFQ), and correlated it with WAI. They found
a moderate to strong correlation between the two
constructs. Based on the results in these studies we as-
sume that work ability is at least moderately correlated
with health-related production loss.
Hypothesis H3a Work ability is expected to have at
least a moderate negative correlation with health-related
production loss (r = −0.30 – -0.50).
Hypothesis H3b Work ability is expected to have at
least a moderate negative correlation with health-related
production loss in patients suffering from N/B pain
(r = −0.30 – -0.50).
Hypothesis H3c Work ability is expected to have at
least a moderate negative correlation with health-
related production loss in patients suffering from
CMD (r = −0.30 – -0.50).
Responsiveness
Responsiveness refers to the ability of an instrument to
detect important changes either in terms of its ability to
change over time, or in terms of how changes to it relate
to corresponding changes in a reference measurement
[25]. The first type of responsiveness is referred to as
“internal responsiveness,” whereas the second type of re-
sponsiveness is referred to as “external responsiveness.”
In this study, we evaluated the responsiveness of the
measure using external responsiveness, i.e., whether
changes in the scores of health-related production loss
should be related to corresponding changes in various
measures of health [25]. For all hypotheses (H4a-c) it
was expected that health-related production loss would
be reduced when health was improved, i.e., the different
constructs were expected to have a negative association
with health-related production loss.
Hypothesis H4a Changes in general health are signifi-
cantly and negatively associated with changes in health-
related production loss.
Hypothesis H4b Changes in HRQL are significantly and
negatively associated with changes in health-related pro-
duction loss.
Hypothesis H4c Changes in work ability are signifi-
cantly and negatively associated with changes in health-
related production loss.
Methods
In 2009, a national implementation of the so-called “re-
habilitation warranty” (RW) began in Sweden. The polit-
ical aim of the RW was to reduce, and prevent, sickness
absenteeism among people suffering from persistent
back/neck pain or CMDs. To accomplish this goal, the
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Swedish government offered economic compensation to
the county councils in order to stimulate the use of
evidence-based rehabilitation, mainly in primary care.
Multimodal rehabilitation was offered for pain syn-
dromes and was given in teams of at least three profes-
sionals (typically a medical doctor, a physiotherapist and
a psychologist). It was usually carried out 2–3 times a
week over a period of 6–8 weeks. Patients suffering from
CMD were given cognitive behavioral therapy, often 8–
10 sessions. Therapists offering cognitive behavioral
therapy had to have at least a basic psychotherapy edu-
cation, or be a licensed psychologist or psychotherapist.
The RW encompasses all individuals of working age
(16–67 years old) who are at risk of long-term sickness
absenteeism due to persistent non-specific musculoskel-
etal pain or common mental disorders. The reason for
focusing on these two diagnosis groups was that they
represent the two most common causes for sick leave in
Sweden. Since one of the goals concerns prevention,
people not currently on sick leave may also take part in
the interventions.
Study design & population
A register-based study of the effects of the RW on sick-
ness absenteeism was carried out in 2010 and included
all individuals (N = 62,691) who had initiated treatment
under the RW during the years 2009–2010. A sample of
this population (N = 969) also participated in a survey,
and received questionnaires to assess their health and
working capacity before and after the interventions.
Twelve county councils volunteered to participate in the
survey. Seventy-four health care units (HCUs) offering
interventions under the RW were selected, using a
stratified random sampling procedure, based on type of
HCU (public/private and primary care/specialized care).
Patients were successively recruited by the staff at the
selected HCUs. The staff was informed that all patients
beginning interventions under the RW should receive
written and oral information about the study and be
asked to participate. Participation involved answering a
brief questionnaire on HRQL and working capacity. The
questionnaire was filled out twice: at the start of the re-
habilitation and six months thereafter. The first ques-
tionnaire was distributed by the staff at the HCU, who
also collected the patients’ informed consent. The sec-
ond questionnaire was administered by the research
team. Because the exact date of rehabilitation termin-
ation was unknown to the researchers, the follow-up
questionnaire was sent out six months after the start of
rehabilitation.
This study includes all patients who responded at the
baseline measurement that they had had a job during the
previous six months, since having a job was a prerequisite
for patients’ being able to answer the questions.
Ethical approval
The study was approved by the Central Ethical Review
Board at Karolinska Institutet in Stockholm (Dnr 2009/
1750-31/1).
Measurements
Health-related production loss was measured with the
question: During the past seven days, how much did your
health problems affect your performance while you were
working? Think about days you were limited in the
amount or kind of work you could do, days you accom-
plished less than you would have liked, or days you could
not do your work as carefully as usual. If health prob-
lems affected your work only a little, choose a low num-
ber. Choose a high number if health problems affected
your work a great deal. The respondents were asked to
rate how much their health-related problems had af-
fected their performance using a scale from 0 to 10,
where 0 = Health problems had no effect on my work,
and 10 = Health problems completely prevented me
from working. The question is based on one of the items
in the Work Productivity Activity Impairment question-
naire (WPAI-GH) [16].
Health conditions
General health was measured using a question from
Short Form-12 (SF-12) [15, 26] (“In general, how would
you say your health is”). The response options were
ranged along a five-point scale from 1 (“excellent”) to 5
(“poor”). In the analyses, the scale was recoded into 1 =
poor to 5 = excellent.
HRQL was measured using the EQ-5D [17]. The EQ-
5D consists of five questions, answered on a three-point
scale and covering the domains of physical mobility, hy-
giene, daily activity, pain, anxiety and depression. An-
swers can be transformed into a summary index ranging
from 0 to 1, in which 0 signifies the worst possible
health and 1 perfect health. Negative values could arise
and needed to be dealt with in the analyses [27]. The
Danish tariff was used to calculate the time trade-off
scores (TTO scores) [28]. This index is a widely used
measure of quality of life in different patient popula-
tions, allowing patient data to be compared with data
from the general population.
Work ability was measured using a single item derived
from the Work Ability Index (WAI) [20, 21], asking
people to rate their present work ability compared to
their lifetime best, on a scale from 0 to 10 where 0 rep-
resents totally incapacitated and 10 represents work abil-
ity when perceived as best. This single question has
previously been shown to be highly correlated with the
entire instrument [29].
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Statistical analyses
Convergent validity
To test for convergent validity (the correlation between
health-related production loss and different health-related
measures), Spearman’s Rank Correlation Coefficient was
used. This was chosen due to the scale of the variables in
the test, where one variable is ordinal numeric and the
other one is continuous. Correlations smaller than 0.1
were interpreted as no correlation, between 0.1 and 0.3 as
a weak correlation, 0.3 to 0.5 as moderate, and 0.5 and
above as a strong correlation [14]. The same categories
were used for negative correlations. This analysis was per-
formed using both the baseline and the follow-up meas-
urement separately for both groups of patients, i.e., both
CMD and back/neck pain patients. When analyzing
HRQL, all individuals who received a negative score—i.e.,
perceived their health to be lower than 0—were excluded.
Responsiveness
The responsiveness was assessed in terms of external re-
sponsiveness, that is, comparing changes in health-related
production loss with changes in external standards [25].
Three measures of health were used as external standards
in this study: HRQL, general health, and work ability. This
part of the analyses included all patients who had had a job
during the previous six months and had responded to both
the baseline and follow-up measurement. All patients who
received a HRQL lower than 0 (negative value) in any of
the measurements were excluded from the analyses when
evaluating the significance of changes in HRQL and health-
related production loss. The analyses were performed using
a linear regression model. Age, gender, educational level,
and the subgroup (back/neck pain and CMD) were in-
cluded in the regression models as covariates.
Results
The total study population consisted of 965 patients.
The participants had a mean age of 41 years (SD 12) and
the majority were women (78 percent), see Table 1. Of
these, 692 (72 %) reported at baseline that they had had
a job during the previous six months and were therefore
included in this study. 88 percent of the population suf-
fering from CMD reported that their disorder resulted
in production loss. This could be compared with 97 per-
cent of those suffering from neck/back pain reporting
production loss due to the problem. The average level of
health-related production loss was 5.26 for the total
population. The reported level of production loss among
those with CMD was on average lower (4.62) than for
people suffering from neck/back pain (6.34).
Convergent validity
The analysis of convergent validity was performed for
both the baseline and the follow-up measurement
(Table 2). The general health score, i.e., from SF-12,
showed a moderate (baseline) to strong (follow-up)
negative correlation with health-related production loss.
HRQL (EQ-5D) had a strong negative correlation with
health-related production loss in both the baseline and
follow-up measurement. Work ability also showed a
strong negative correlation with health-related produc-
tion loss. Some differences were found between the two
subgroups (Table 3). These results support a majority of
hypotheses H1a-H3c, while some hypotheses were only
partly supported (H1a, H1c and H2a).
Responsiveness
Changes in health-related production loss were signifi-
cantly associated with changes in general health, HRQL,
and work ability (Table 4). This finding supports hypoth-
eses H4a-H4c, indicating that the measure has external
responsiveness. No differences were found for the two
subgroups, indicating that the measure is responsive
when used for the different types of health problems in
this study.
Discussion
This study expands the existing research on a measure
of health-related production loss developed in Sweden
by examining its construct validity and responsiveness in
a population suffering from persistent back/neck pain or
CMDs. Based on previous research into the construct
validity of health-related production loss evaluated in re-
lation to health conditions, the investigated measure
provided the expected results and confirmed a majority
of the hypotheses. In some cases (4 out of 18), the ob-
served correlations were stronger than expected. That
14 out of 18 hypotheses were confirmed indicates that
the instrument has good construct validity. This study
also showed that changes in health conditions and work
ability were significantly related to changes in health-
related production loss, which indicates that the meas-
ure also has good external responsiveness.
It is a challenge to evaluate presenteeism, and the
resulting production loss, over time. Health could be a
good indicator of presenteeism and production loss, but
presenteeism could also be affected by other things such
as feelings of insecurity, which could affect the strengths
of association of health and presenteeism/production
loss. Job insecurity, for example, is important for people
in their decisions to go to work despite poor health [30].
If employees feel more insecure about their job, or if
there were changes to the regulations governing the
right to sick leave, this could affect the distribution of
the ratings in both instruments. A wider distribution of
the rating could result in stronger correlations. There-
fore, an increase in correlation strength between general
health and production loss from baseline to follow-up
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Table 1 Description of the study population
Total population CMD Back/neck pain Differences between
groupsN = 965 N = 556 N = 409
Diagnostic groups, n (%)
Back/neck pain 409 (42) - -
CMD 556 (58) - -
Sex, n (%) p = 0.001a
Women 752 (78) 413 (74) 339 (93)
Men 213 (22) 143 (26) 70 (17)
Education, n (%) p = 0.017a
University 298 (31) 191 (34) 107 (26)
High school 539 (57) 302 (55) 237 (59)
Preschool 119 (12) 60 (11) 59 (15)
Age, mean (sd) 41.02 (11.5) 38.52 (11.8) 44.40 (10.2) p < 0.001b
HRQL, m (sd), Range 0-1 0.55 (0.28) 0.63 (0.25) 0.45 (0.34) p < 0.001b
General health, n (%) p < 0.001a
Excellent 4 (0) 2 (0) 2 (0)
Very good 64 (7) 54 (10) 10 (3)
Good 215 (22) 165 (30) 50 (12)
Somewhat good 450 (47) 246 (44) 204 (50)
Poor 229 (24) 86 (16) 143 (35)
Work ability, mean (sd), Range 0-10 4.49 (2.7) 5.19 (2.7) 3.54 (2.5) p < 0.001b
Worked the previous 6 months, n (%) p < 0.001a
Yes 692 (72) 434 (79) 258 (63)
No 267 (28) 118 (21) 149 (37)
Production loss, n (%) p < 0.001a
Yes 619 (92) 372 (88) 247 (97)
No 57 (8) 50 (12) 7 (3)
Production loss, mean (sd), Range 0-10 5.26 (3.05) 4.62 (3.10) 6.34 (2.65) p < 0.001b
CMD Common mental disorders
a = Tested with Pearson Chi-square test
b = Tested with Students t-test
Table 2 Convergent validity. Expected and observed correlations of health-related production loss with health indicators. Total
population
Health-related production loss, Baseline Expected correlation Observed correlation P-value
General health Moderate (−0.30 – -0.50) Moderate (−0.422)a <0.001
HRQL Moderate (−0.30 – -0.50) Strong (−0.525)b <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.691)a <0.001
Health-related production loss, Follow-up
General health Moderate (−0.30 – -0.50) Strong (−0.551)b <0.001
HRQL Moderate (−0.30 – -0.50) Strong (−0.543)b <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.650)a <0.001
aExpectations confirmed
bCorrelations stronger than expected
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measurement does not necessarily mean that the instru-
ment has poor construct validity. It could also be an in-
dicator of some impact from external changes. A
difference in strengths in correlation over time was also
found in the validation study of WPAI [16], of which this
item is based.
The correlation matrix of the measures indicates that
when the health of the respondents improved, health-
related production loss decreased. This pattern was the
same for both groups of patients (CMD and back/neck
pain). Even though the strength of the correlations was
similar for the two subgroups, i.e., fulfilled the
Table 3 Convergent validity. Expected and observed correlations of health-related production loss with health indicators. Different
subgroups
Health-related production loss, Baseline, B/N Pain Expected correlation Observed correlation P-value
General health Moderate (−0.30 – -0.50) Moderate (−0.323)a <0.001
HRQL Moderate (−0.30 – -0.50) Moderate (−0.433)a <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.638)a <0.001
Health-related production loss, Follow-up, B/N Pain
General health Moderate (−0.30 – -0.50) Moderate (−0.404)a <0.001
HRQL Moderate (−0.30 – -0.50) Moderate (−0.430)a <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.581)a <0.001
Health-related production loss, Baseline, CMD
General health Moderate (−0.30 – -0.50) Moderate (−0.408)a <0.001
HRQL Moderate (−0.30 – -0.50) Moderate (−0.491)a <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.690)a <0.001
Health-related production loss, Follow-up, CMD
General health Moderate (−0.30 – -0.50) Strong (−0.558)b <0.001
HRQL Moderate (−0.30 – -0.50) Moderate (−0.484)a <0.001
Work ability At least moderate (−0.30 – -0.50) Strong (−0.639)a <0.001
aExpectations confirmed
bCorrelations stronger than expected
Table 4 Responsiveness validity. Mean change in different health indicators, and results from regression analysis evaluating
responsiveness
Difference Follow-up-baseline Total population
Mean (SD) β CI
Health-related production loss −1.408 (3.406)















*Significant at p-value ≤ 0.05
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requirements for being moderately or strongly corre-
lated, the correlation estimate was higher for the popula-
tion with CMD than for the population with back/neck
pain. From this point of view, the measure seems to cap-
ture health-related production loss better among indi-
viduals with CMD than among those with neck/back
pain.
Work ability has rarely been evaluated in relation to
health-related production loss. In one study it was
shown that perceived work ability may be a robust indi-
cator for assessing perceived production loss [22]. That
study used estimates of work ability from a different
population and modeled it against information on
health-related production loss. The present study adds
to current knowledge by also showing, using data col-
lected in the same population, that work ability and
health-related production loss are related to each other.
Another study [23] validated a measure of work func-
tioning, which is related to work ability and production
loss, by testing its correlation with both WAI and pro-
duction loss. Both WAI and production loss had a cor-
relation with work functioning that was lower than that
observed between WAI and production loss in the
present study. Since no other study was found that has
tested for the association between WAI and production
loss, it is difficult to determine whether the correlations
found in the present study were too strong to conclude
good construct validity or if they were as strong as could
have been expected, which would suggest good con-
struct validity.
Work ability is a concept commonly used in Sweden
to determine whether a person will be eligible for sick
pay or not. The Swedish social insurance agency has
begun specifically to evaluate whether people have the
ability to work rather than evaluating their health status
when deciding whether to grant an application for sick
leave [31]. In the present study, work ability showed a
stronger correlation with production loss than did other
measures of health. Thus, if the measure of health-
related production loss works as intended, work ability
and health-related production loss capture the related
dimensions and both measures could be used to assess
people’s ability to perform at work. This also indicates
that work ability is a better measure than health for cap-
turing reductions in people’s ability to perform at work.
It is well known that the health of an individual is dir-
ectly associated to performance [2, 32, 33]. People with
health problems tend to be less productive than healthy
employees. There also seems to be a difference in how
different health conditions affect the ability to perform
at work, at least in terms of the subjective performance
level. In the present study, the average health-related
production loss differed between the group reporting
CMD and those experiencing back/neck pains. The
average reduction in performance level was greater
among people with back/neck pains. From both the
company and societal perspective, this could indicate
that, on an individual level, back/neck pain is a more
costly health problem than CMD, as the individual’s abil-
ity to perform at work is affected to a greater extent.
The average reduction in performance among individ-
uals with back/neck pain in this population, who were
recruited to obtain early interventions for their health
problem to avoid sickness absence, or in some cases to
return to work, was 6.34 on a scale from 0 to 10, where
10 means that health problems completely prevented
them from working. The corresponding value for the in-
dividuals with CMD was 4.62. This scale is usually con-
verted from 0 to 10 up to 0 to 100 in order to capture
production loss in terms of a percentage [9]. This means
that the difference between the two groups is more than
17 percent.
The measure used in the present study asks people to
rate how health-related problems affected their ability to
perform while at work over the previous seven days.
This measure is derived from WPAI presenteeism di-
mension [16], but differs in asking whether health affects
their performance rather than about the effect on prod-
uctivity. WPAI is an instrument that has been used in
several studies and is one of the most extensively tested
work productivity instruments to date [34]. It has several
strengths besides the rigorous validation testing, such as
the inclusion of production loss measures in several do-
mains and a short completion time. The limitations,
however, are that is does not consider compensation
mechanisms or work team dynamics [34] and that it
only captures health-related production loss [11]. The
latter is especially important if the purpose is to assess
total production loss at the workplace, i.e., reduced per-
formance due to work environment-related problems as
well as health-related problems and absenteeism. This
validation of the health-related production loss item is a
first step towards creating a valid and reliable question-
naire consisting of those three dimensions (absenteeism,
work environment-related loss and health-related loss)
in order to capture a more comprehensive picture of
production loss at the workplace. Previous validation
studies on production loss instruments have mainly been
conducted on cross-sectional data, while longitudinal
validity tests barely exist [34]. In the present study valid-
ation is conducted using both cross-sectional and longitu-
dinal data, indicating good validity also when considering
responsiveness. The reliability of asking people to rate
their own performance has been under discussion, with
some questioning the accuracy of the information in rela-
tion to actual productivity. There have been suggestions
that people tend to overrate their performance because
they are afraid of telling the truth in case this information
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should become known to the employer, or that people
overestimate their production loss and that the effect on
output is lower than estimated [35]. In a previous study
evaluating the construct validity of the Health Perform-
ance Questionnaire [36], the measure where people were
asked to rate their own performance level was shown to
have the highest correlation with both mental and physical
health. This was compared to others measures where the
employees were asked, for example, to rate their perform-
ance compared to other workers in similar occupations.
These measures showed weaker correlations with both
mental and physical health. The authors therefore suggest
that this measure, where the employees rate their own
performance alone, is sufficient when calculating the cost
of presenteeism [36]. As the measure used in the present
study is similar to the one in the Scuffham et al. study
[36]—i.e., the individuals were asked to rate their own per-
formance levels—, this could indicate that the measure is
also suitable for calculating the cost of presenteeism. To
be able to justify this conclusion, subjective measures of
production loss need to be validated against objective
measures of production.
Limitations
As can been seen in Table 1, the individuals with CMD
were more healthy than those with back/neck pain at
baseline. They rated their general health as slightly bet-
ter, reported better work ability on average and had
fewer numbers reporting that they had not been working
during the previous six months. Also, a larger propor-
tion of them had a university education than in back/
neck pain group. It is possible that the difference in pro-
duction loss ratings is due to the severity of the prob-
lems resulting in long term sick leave for back/neck pain
patients to a higher extent than for CMD patients. How-
ever, this problem should have a limited effect as we
only used those who had had a job during the previous
six months. It is also possible that the difference in pro-
duction loss could be explained by the type of job, as
well as by the ability of respondents to adapt their job
tasks to their current state of health, which would result
in lower levels of production loss, or that their ability to
perform at work is not affected to the same extent as it
is for back/neck pain patients. This could be indicated
by the difference in educational level between the two
groups. Unfortunately, no information about patients’
job types was collected in the study to enable testing for
that. In a recently published study comparing produc-
tion loss due to sick leave for patients with CMD and
back/neck pain in a Swedish setting, differences were
found between job types [37]. White-collar professions
were more common in the group with CMD whereas
blue-collar professions were more common in the back/
neck pain group. This supports the explanation that the
lower levels of production loss could be an effect of how
people’s ability to perform is affected by the kind of job
they have, and not only by their health.
Another limitation is that the data does not discrimin-
ate between those on full-time sick leave and those
partly in work at baseline. The only information avail-
able is whether they have had a job during the previous
six months. In this study the aim was to evaluate the val-
idity of the instrument, i.e., if people’s ability to perform
at work was correlated with their health. People who
rate their production loss as high are assumed also to
rate their health as poor, and a reduction in health-
related production loss should be accompanied by an
improvement in health and vice versa. A person on sick
leave should theoretically quote a high loss or leave the
question unanswered (since it specifically asks about the
previous seven days), and at the same time rate their
work ability or general health as poor. For this reason
we don’t think this limitation affects the ability to use
the data for validation of this measure, but we do think
it is important to have this in mind when reflecting upon
the results.
Future research
This measure of production loss has so far been evalu-
ated with regard to its construct validity and responsive-
ness. Future studies investigating its validity with regard
to objective production data and to other validated per-
formance measurements, as well as studies evaluating
the stability of the measure, are needed.
Conclusion
The present study demonstrates that this measure of
health-related production loss is a valid measure captur-
ing production loss due to illness, and that work ability
is more strongly associated with health-related produc-
tion loss than people’s general health is. Sickness presen-
teeism—that is, being sick but at work—is a costly
matter for employers. The results of this study show an
average of about 50 % reduced production due to illness
among employees, with back pain being the most costly.
The potential economic benefit of interventions to pre-
vent work-related illness is highlighted by these results.
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